The present study was also supported by funds from the AMED-CREST from the Japan Agency for Medical Research and Development, AMED and research funds from the Yamagata prefectural government and the City of Tsuruoka
It is always important to talk to your healthcare provider about the potential risks and benefits of Saxenda before choosing to start this medication
Glucagon-like peptide-1 receptor agonists for non-alcoholic fatty liver disease in type 2 diabetes: A meta-analysis
J Neurochem 139(Suppl 2):136153 Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, Jbabdi S, Taschler B, Keating P, Winkler AM, Collins R, Matthews PM, Allen N, Miller KL, Nichols TE, Smith SM (2022) SARS-COV-2 is associated with changes in brain structure in uk biobank